A high-fibre diet could protect against flu and colds

Researchers from the Monash University in Australia found that mice which are given extra fibre are protected against influenza, which affects millions of people every year.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Carolyn M. Boudreau, Galit Alter
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Influenza is a common viral infection worldwide. Maoto (ma-huang-tang) was developed in ancient China and is used to alleviate flu symptoms. Currently, no meta-analyses have evaluated the efficacy and safety of m...
Source: BMC Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Tags: Research article Source Type: research
Conclusion: The outbreak started in the late monsoon (January) of 2017 and had two peaks; one in summer months and another in winter months. Influenza B virus was reported from December 2017 to May 2018. Age groups ≤5 years and 6–18 years had higher positivity as compared to other age groups. Regular surveillance programmes are required for assessing the trends of influenza infections due to various subtypes and to plan timely and adequate steps for preventing the spread to larger vulnerable population.
Source: Indian Journal of Medical Microbiology - Category: Microbiology Authors: Source Type: research
Publication date: April 2019Source: Antiviral Research, Volume 164Author(s): Sergey A. Tarasov, Vladimir V. Zarubaev, Evgeniy A. Gorbunov, Svetlana A. Sergeeva, Oleg I. Epstein
Source: Antiviral Therapy - Category: Virology Source Type: research
In this study, we characterized the antiviral properties of the most promising compounds as well as investigated their propensity to induce drug resistance. Our results show that some of the selected compounds possess potent, broad-spectrum anti-influenza activity as they efficiently inhibited the replication of several strains of influenza A and B viruses, including an oseltamivir-resistant clinical isolate, with nanomolar or low-micromolar potency. The most promising compounds specifically inhibited the PA−PB1 binding in vitro and interfered with the influenza A virus polymerase activity in a cellular context, with...
Source: Antiviral Therapy - Category: Virology Source Type: research
We examined use of preventive care and cancer screening services in cancer survivors and comparison adults with/without SPD. Multivariable logistic regression models were conducted for each outcome: preventive service (i.e. blood pressure, cholesterol, influenza vaccination, routine and dental check-up) or cancer screening (i.e. mammography, Papanicolau test, colorectal cancer screening) adjusting for demographic, comorbidity, usual source of care covariates. Adjusted odds ratios and 95% confidence intervals were calculated. Prevalence of SPD was 9.8% in cancer survivors compared to 4.6% in comparison adults. Survivors wit...
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Compound protects mice from lethal forms of influenza. Chemists could use a similar design approach to target other viruses
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
ConclusionsHepB vaccination initiation and completion were associated with a number of characteristics that can be utilized to develop strategies to increase HepB vaccination coverage among adults traveling to a country of high or intermediate endemicity.
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
ConclusionsHepA vaccination initiation and completion was associated with a number of characteristics, which can be used to develop strategies to increase HepA vaccination coverage among adults traveling to a country of high or intermediate endemicity.
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
Publication date: Available online 15 March 2019Source: International Journal of PharmaceuticsAuthor(s): Célia Jacoberger-Foissac, Hanadi Saliba, Cendrine Seguin, Anaïs Brion, Zahra Kakhi, Benoît Frisch, Sylvie Fournel, Béatrice HeurtaultAbstractTherapeutic cancer vaccines need thoughtful design to efficiently deliver appropriate antigens and adjuvants to the immune system. In the current study, we took advantage of the versatility of a liposomal platform to conceive and customize vaccines containing three elements needed for the induction of efficient antitumor immunity: i) a CD4 epitope peptide a...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Australia Health | Diets | Fibre | Health | Influenza | Nutrition